VS

Vishal Satish Surve

Active Director Director DIN 08676463
DIN 08676463 First appointment Jan 2020 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since Jan 2020
Shareholding value •••• Premium profile

About Vishal Satish Surve

Data last updated:

Vishal Satish Surve has 6 years in corporate governance. Holds Director and Designated Partner roles. Currently with 5 companies, including Bionex Vetcare Private Limited and Avicura Pharmaceuticals Private Limited. Formerly with 1 company, such as Vogofy Industries Private Limited. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹28.29 Cr; the largest is Vetecura Life Sciences Private Limited at ₹15.71 Cr (FY 2025).

DIN 08676463
Primary Designation Director
First Appointment 22 Jan 2020
Oldest Company Age 8 yrs
Largest company Vetecura Life Sciences Private Limited · ₹15.71 Cr (FY 2025)
Combined revenue ₹28.29 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Mar 20202018₹15.71 Cr (FY 2025)Active
Director22 Jan 20202020₹12.32 Cr (FY 2025)Active
Bionex Vetcare Private Limited U24110MH2022PTC387382
Director22 Jul 20222022₹26 Lakh (FY 2025)Active
Adyukta Alliance Private Limited U46201MH2024PTC436344
Director12 Dec 20242024–Active
Designated Partner08 Aug 20242024–Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vogofy Industries Private Limited U74999MH2020PTC348324
Director20 Oct 20202020₹2.36 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Bionex Vetcare Private Limited
Avicura Pharmaceuticals Private Limited
Vetecura Life Sciences Private Limited
Adyukta Alliance Private Limited
Premium access

Shareholding and investment profile for Vishal Satish Surve

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vishal Satish Surve

Vishal Satish Surve has 6 years in corporate governance. Holds Director and Designated Partner roles. Currently with 5 companies, including Bionex Vetcare Private Limited and Avicura Pharmaceuticals Private Limited. Formerly with 1 company, such as Vogofy Industries Private Limited. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹28.29 Cr; the largest is Vetecura Life Sciences Private Limited at ₹15.71 Cr (FY 2025).

Vishal Satish Surve is associated with 5 companies as Director and Designated Partner, including Vetecura Life Sciences Private Limited (₹15.71 Cr), Avicura Pharmaceuticals Private Limited (₹12.32 Cr), Bionex Vetcare Private Limited (₹26 Lakh).

Vishal Satish Surve has expertise in General Business.

Vishal Satish Surve has 6 years in corporate governance.

By reported revenue, the largest current company of Vishal Satish Surve is Vetecura Life Sciences Private Limited, with revenue of ₹15.71 Cr (FY 2025).

The 3 current companies of Vishal Satish Surve that report revenue have a combined latest revenue of ₹28.29 Cr.

Vishal Satish Surve currently holds positions at 5 companies: Vetecura Life Sciences Private Limited (₹15.71 Cr), Avicura Pharmaceuticals Private Limited (₹12.32 Cr), Bionex Vetcare Private Limited (₹26 Lakh), Adyukta Alliance Private Limited, Shivanshi Giftcraft Llp.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available